
IndraLab
Statements
reach
"At the same time, MALT1 could function as a protease activity upon TCR and CD28 co-stimulation to inactivate negative regulators of NF-kappaB signaling such as the A20 (also known as TNFAIP3), CYLD (cylindromatosis), RNase Regnase-1 as well as RelB and HOIL1 [XREF_BIBR - XREF_BIBR]."
reach
"Altogether, our findings establish an important role for MALT1-mediated CYLD cleavage in BCR signaling, canonical NF-κB activity, and consequently cell growth of BCR-dependent lymphomas, thereby providing novel insights into targeting MALT1 protease activity and ubiquitination enzymes as a promising therapeutic approach for these aggressive lymphomas."
reach
"Taken together, our data revealed that (1) CYLD is cleaved by MALT1, (2) these MALT1-mediated cleavage products of CYLD undergo rapid proteasomal degradation (inactivation), and (3) CYLD represses NF-κB activity and cell growth; hence, MALT-mediated cleavage of CYLD promotes NF-κB activity and growth of aggressive B-cell receptor-dependent lymphomas."
reach
"Taken together, our findings identify an important role for MALT1-mediated CYLD cleavage in BCR signaling, NF-kappaB activation and cell proliferation, which provides novel insights into the underlying molecular mechanisms and clinical potential of inhibitors of MALT1 and ubiquitination enzymes as promising therapeutics for DLBCL, MCL and potentially other B-cell malignancies."
reach
"Interestingly, treatment with a broad spectrum inhibitor of protein kinase C (PKC) enzymes, which are known upstream activators of CARD14 family proteins [43], not only failed to inhibit NF-κB/JNK/Akt phosphorylation, but also MALT1-mediated CYLD and A20 cleavage (Figure 5A), suggesting that constitutive CBM activation in PCa cells is mediated by a PKC-independent mechanism.While the scaffold function of MALT1 is required for NF-κB activation and gene expression, MALT1 proteolytic activity mainly controls gene expression at the posttranscriptional level by regulating mRNA stability of specific genes, including IL-6, in an NF-κB-independent manner (Figure 4A) [40]."